Civica Infrastructure Inc. company information, Employees & Contact Information

Civica long-acting insulin available on January 1, 2026 Breakthrough T1D

Civica to launch affordable long-acting insulin in pre-filled pens in 2026 Drug Delivery Business

Civica To Launch Long-Acting Insulin Glargine in the US in January 2026 PR Newswire

Civica to start selling long-acting insulin in January 2026 Virginia Business

Europe: 4 Transnational Courses Organised by CIVICA's 10 Universities Sciences Po

State providing $3M to support drugmaker’s insulin development project in Petersburg Richmond BizSense

Civica to market Biocon Biologics Insulin Glargine in US ET Pharma

Civica Media Acquires Greenleaf Book Group and Amplify Publishing Group To Create The Leader In Thought Leadership and Hybrid Book Publishing Yahoo Finance

Private Equity Firm Acquires Two Leading Hybrid Publishers Publishers Weekly

Biocon Biologics and Civica launch private-label Insulin glargine Indian Pharma Post

Civica touts a study that ‘validates’ its model for selling low-cost generics statnews.com

Biocon Biologics expands Civica tie-up to launch pvt-label insulin in US Business Standard

Newsom committed California to making its own insulin. It's at least a year behind his schedule CalMatters

Civica to start Chesterfield lab construction this summer, eyes Petersburg plant expansion Richmond BizSense

Biocon Biologics and Civica, Inc. Collaborate to Expand Insulin Aspart Access in the United States PR Newswire

Advocating for Social Sciences in Higher Education: Sciences Po at the CIVICA Global Forum Sciences Po

Civica Appoints Dave Sehgal as Chief Manufacturing Officer and Supply Chain Officer PR Newswire

Sciences Po and Its CIVICA Partners Stand for Academic Freedom & University Autonomy Sciences Po

Governor Glenn Youngkin Announces $3 Million Grant to Support Civica's Affordable Insulin Programs PR Newswire

Partners Group Said to Weigh $2 Billion Sale of Tech Firm Civica Private Equity Insights

Civica Continues to Deliver on Its Mission to Prevent Drug Shortages - Expands Membership with Four New U.S. Hospital Organizations PR Newswire

Biocon Biologics and Civica expand partnership The Hans India

GdS: Arena Civica chosen as venue for Milan-Cagliari Coppa Italia Primavera final SempreMilan

Stanford, Essentia and other health systems join Civica Modern Healthcare News

Only 1% of managers call their hiring 'very effective' – Civica research shows why Civil Service World

University of Miami buys shopping center for $68 million The Business Journals

Biocon Biologics, Civica partner to expand Insulin Aspart access in the US Business Standard

Cloud-native social care management services provider bought by software firm in “exciting new chapter” Insider Media Ltd

European Youth: Meet Our CIVICA Student Ambassadors 2024 Sciences Po

Civica, co-founded by SSM Health, plans to make affordable insulin SSM Health

Civica Rx Gets More Backing in Effort to Reduce Drug Prices and Shortages American Hospital Association

CIVICA Student Engagement Fund – summary of the first call Gazeta SGH

Blackstone to Buy U.K. Software Developer Civica The Wall Street Journal

Insulin Affordability? Yes, Please: Breakthrough T1D Joins Civica to Make Low-Cost Insulin Available to All Americans Breakthrough T1D

Civica Rx Aims to Disrupt Generic Insulin Market Pricing by 2024 American Hospital Association

Biocon arm joins hands with Civica to expand diabetic drug in US Business Standard

Wipro A/NZ country head Christopher Smith joins Civica as APAC leader Consultancy.com.au

GOVERNOR NEWSOM ANNOUNCES $30 INSULIN THROUGH CALRX California State Portal | CA.gov

Vaccinating Health Care Supply Chains Against Market Failure: The Case of Civica Rx NEJM Catalyst

​Low-Cost Insulin One Step Closer with California-Civica Partnership Blue Shield of California | News Center

Civica Rx considers moving into chemo drugs as shortages worsen statnews.com

Unlocking knowledge: How Civica enhances Singapore’s school libraries GovInsider

Civica Investment Strengthens Essential Medicines Partnership in Petersburg Virginia Economic Development Partnership

Civica to Make California's own Insulin Brand Making Sense of Diabetes

Civica’s Plan for Affordable Insulin Proves we can Bring Transparency to the Drug Market Stanford Medicine

CIVICA Presidents’ Committee 2025: Shaping the future of European social sciences Gazeta SGH

California Selects Civica Rx as Its Insulin Manufacturing Partner Arnold Ventures

Non-profit drug maker will provide insulin for no more than $30 a vial CNN

Civica Rx to make, distribute low-cost insulin Fierce Healthcare

California invests $50M to partner with Civica Rx on insulin manufacturing Fierce Pharma

Chris Smith joins Civica as APAC leader ARNnet

Not-for-profit Generic Drug Company Officially Established, Attracts Interest of More Than 120 Health Organizations Intermountain Health Newsroom

Civica Rx opens Utah headquarters American Hospital Association

Civica Rx’s Unique Business Model Improves Drug Supply Security, Cuts Costs: Study BioSpace

California Picks Generic Drug Company Civica to Produce Low-Cost Insulin California Healthline

FAA Greenlights 301-Foot-Tall Residential Tower For Civica Center Phase II In Miami Florida YIMBY

Civica taps Ned McCoy as new CEO Fierce Healthcare

Civica to Build an Essential Medicines Manufacturing Facility Intermountain Health Newsroom

Civica Rx Aims to Bring $30 Insulin to Market in 2024 Beyond Type 1

Civica targets insulin in effort to produce cheaper drugs BioPharma Dive

California expected to partner with nonprofit Civica Rx to produce its own low-cost insulin, sources say NBC News

Nonprofit Civica’s New High-value Filling Lines Produce Insulin and More Healthcare Packaging

How the not-for-profit Civica Rx will disrupt the generic drug industry statnews.com

Unlocking Efficiency: City of Marion’s Civica success Inside Local Government

How Civica Rx Aims to Change the U.S. Insulin Market Beyond Type 1

Biocon shares climb 1% on partnership with Civica to boost insulin aspart availability in the US The Economic Times

UDRB Filing Shows Updated Design And Building Program For Civica Center Phase II At 1050 NW 14th Street In Miami Florida YIMBY

Civica adds Loop Software to its suite of local acquisitions ARNnet

Biblioteca Civica Gambalunga Atlas Obscura

Disrupting Drug Market Prices and Supply NEJM Catalyst

Nonprofit drugmaker Civica Rx is taking aim at the high insulin prices harming people with diabetes The Conversation

Nonprofit Civica Plans to Deliver Low-Cost Insulin Making Sense of Diabetes

Civica Rx lays out $124M sterile injectables plant, pegged to supply COVID-19 drugs and more Fierce Pharma

Civica Rx Welcomes New Founding Members as 12 Additional Health Systems Join Forces to Reduce Chronic Drug Shortages Intermountain Health Newsroom

U.K.-Based Gov Tech Firm Civica Acquired by Blackstone GovTech

Civica taps current COO to succeed VanTrieste as chief executive Healthcare Dive

Novartis partners with Civica Rx to ease hospital shortages for 6 high-demand generic injectables Fierce Pharma

How Civica helped under-the-radar Phlow nab a $354M COVID-19 manufacturing deal Fierce Pharma

Insulin prices have dropped — will Civica still be a disrupter in the field? Pharma Voice

After much fanfare, Civica Rx delivers its 1st drugs Healthcare Dive

Cyberattack hits three English councils at once, as outsourcer Civica denies blame The Record from Recorded Future News

Civica signs up Profil to run trials for affordable insulin biosimilars Fierce Biotech

European Cooperation: Meet Our New CIVICA Students Ambassadors Sciences Po

Civica Rx to build drug manufacturing facility to make sterile injectables Fierce Healthcare

Building the European Library of the Future Through Our CIVICA Alliance Sciences Po

Kaiser Permanente Joins Forces with Civica Rx to Improve Availability and Affordability of Essential Generic Medications PR Newswire

Civica aims to launch low-cost insulin in U.S. by 2024 Reuters

Pharma stock jumps after partnering with Civica to expand Insulin Aspart access in US Trade Brains

CivicaScript, the Newly Named Civica Initiative to Serve Patients in Retail Markets, Announces a New Health Plan Partner, a New President, and a New Drug Manufacturing Partner Business Wire

Civica Rx begins selling its first outpatient generic drug as it tries to overhaul the pharmaceutical supply chain statnews.com

Civica Partners with Ypsomed for Insulin Injection Pen Contract Pharma

Public Pharma’s Biggest Barrier The American Prospect

Latest Civica Rx pact aims to ease shortage of emergency medicine BioPharma Dive

Xellia to produce antibiotics for hospital-backed Civica Rx Fierce Pharma

Nonprofit drugmaker Civica Rx aims to cure a health care system ailment The Conversation

CIVICA Colorado hires new principal amid community backlash over founding principal’s dismissal Greeley Tribune

Hospitals Prepare To Launch Their Own Drug Company To Fight High Prices And Shortages NPR

A group of hospitals has a plan to get around Congress’s refusal to lower the cost of insulin The Washington Post

Phlow: Civica's new Petersburg-based facility will make Central Virginia a national leader The Progress Index

“An indelible mark on my student experience”: Spotlight on the CIVICA Engage Track Course Sciences Po